Search

everythinglearnresearchcommunity

for

Search:↓

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Being overweight can cause or worsen skin problems in children, some more common in darker skin, and is often linked to insulin resistance.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Zinc can help with some skin problems, but its effectiveness varies depending on the condition.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

New treatments for PCOS focus on managing symptoms and improving fertility.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.